Showing results (171-180 of 242) with videos related to
Sort By:
Pageof 25
Nature Biotechnology|December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomasYinghui Zhou, William M Rideout, Tong Zi, et al.Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.Genes & Development|July 5, 2013
Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasisJessie Yanxiang Guo, Gizem Karsli-Uzunbas, Robin Mathew, et al.Nature|December 16, 2021
Spatial genomics enables multi-modal study of clonal heterogeneity in tissuesTongtong Zhao, Zachary D Chiang, Julia W Morriss, et al.Molecular and Cellular Biology|October 1, 2004
Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389Wendy Bruins, Edwin Zwart, Laura D Attardi, et al.Nature Cancer|November 5, 2021
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancerPeter M K Westcott, Nathan J Sacks, Jason M Schenkel, et al.Proceedings of the National Academy of Sciences of the United States of America|October 6, 2016
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinomaDavid G McFadden, Katerina Politi, Arjun Bhutkar, et al.International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcomaSam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.Cancer Cell|July 25, 2020
Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung AdenocarcinomaLindsay M LaFave, Vinay K Kartha, Sai Ma, et al.Nature|April 8, 2011
Suppression of lung adenocarcinoma progression by Nkx2-1Monte M Winslow, Talya L Dayton, Roel G W Verhaak, et al.Pageof 25